Barbara Weber Tango Therapeutics, Inc. (TNGX) insider trading activity

Barbara Weber is Chief Executive Officer of Tango Therapeutics, Inc.. Currently has a direct ownership of 1.62 Million shares of TNGX, which is worth approximately $12.9 Million. The most recent transaction as insider was on Feb 05, 2025, when has been sold 9,013 shares (Common Stock) at a price of $3.16 per share, resulting in proceeds of $28,481. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.62M

0% 3M change

5.67% 12M change

Total Value Held $12.9 Million

Barbara Weber Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 05 2025	SELL Open market or private sale	$28,481 $3.16 p/Share	9,013 Reduced 0.55%	1,622,251 Common Stock
Feb 04 2025	SELL Open market or private sale	$29,236 $2.99 p/Share	9,778 Reduced 0.6%	1,631,264 Common Stock
Feb 03 2025	BUY Grant, award, or other acquisition	-	105,875 Added 6.06%	1,641,042 Common Stock
Feb 07 2024	SELL Open market or private sale	$56,247 $12.62 p/Share	4,457 Reduced 0.29%	1,535,167 Common Stock
Feb 06 2024	SELL Open market or private sale	$58,793 $12.56 p/Share	4,681 Reduced 0.3%	1,539,624 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	87,168 Added 50.0%	87,168 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	89,545 Added 5.79%	1,457,137 Common Stock

Also insider at

RVMD

Revolution Medicines, Inc. Healthcare

Barbara Weber

Chief Executive Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNGX shares.

Notify only if

Value

Insider Trading

Get notified when an Tango Therapeutics, Inc. insider buys or sells TNGX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Tango Therapeutics, Inc.

Track Activities on TNGX

Account